Gastric and Gastro-esophageal Junction Cancer
Conditions
Interventions
Physicians that treat advanced/metastatic GC/GEJC:NA
Physicians that treat locally advanced GC/GEJC:NA
Pathologists:NA
Sponsors
Harbin Medical University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: •Physician titled vice chief or chief physician (also applicable for pathologists); •Physician with over five years’ experience on diagnosis or treatment of GC/GEJC patients(also applicable for pathologists); •Patient volume: medical oncologists with =10 GC/GEJC patients per month, radiationoncologists or surgeons with =5 GC/GEJC patients per month in the most recent 3months of practice; •Pathologist experienced in biomarker testing in advanced GC/LAGC, with testing sample=5 per month in the most recent 3 months of practice; •All eligible physicians need to confirm and sign up the informed consent form (ICF).
Exclusion criteria
Exclusion criteria: •Unwilling to provide electronic ICF to participate in the survey.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment pattern of advanced GC/GEJC;Treatment pattern of locally advanced GC/GEJC (including resectable and unresectable LAGC);Biomarker testing status and factors affecting performance of testing; | — |
Countries
China
Contacts
Public ContactZhang Yanqiao
Harbin Medical University Cancer Hospital
Outcome results
None listed